Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.98% |
AMGEN INC. | AMGN | 6.61% |
GILEAD SCIENCES, INC. | GILD | 5.04% |
VERTEX PHARMACEUTICALS | VRTX | 4.50% |
REGENERON PHARMACEUTICALS | REGN | 4.49% |
CORTEVA INC | CTVA | 3.30% |
BIOGEN IDEC, INC. | BIIB | 3.29% |
SEAGEN INC | SGEN | 3.07% |
ASTRAZENECA PLC ADR | AZN | 2.96% |
MODERNA INC | MRNA | 2.92% |
HORIZON THERAPEUTICS PLC | HZNP | 2.78% |
ILLUMINA INC | ILMN | 2.21% |
BIOMARIN PHARMACEUTICAL | BMRN | 2.18% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.13% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.94% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.86% |
VIATRIS INC | VTRS | 1.81% |
SAREPTA THERAPEU | SRPT | 1.75% |
EXACT SCIENCES | EXAS | 1.75% |
INCYTE CORP | INCY | 1.73% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.53% |
UNITED THERAPEUTICS CORP | UTHR | 1.50% |
IONIS PHARMACEUTICALS, IN | IONS | 1.46% |
ALKERMES PLC | ALKS | 1.40% |
EXELIXIS, INC. | EXEL | 1.40% |
ARGENX SE - ADR | ARGX | 1.28% |
HALOZYME THERAPEUTICS INC | HALO | 1.22% |
CRISPR THERAPEUTICS AG | CRSP | 1.20% |
SYNEOS HEALTH, INC. | SYNH | 1.14% |
APELLIS PHARMACE | APLS | 1.13% |
MEDPACE HOLDINGS | MEDP | 1.11% |
NATERA INC | NTRA | 1.09% |
BIONTECH SE-ADR | BNTX | 1.08% |
VAXCYTE INC | PCVX | 1.04% |
IMMUNOGEN INC | IMGN | 1.03% |
INSMED INC | INSM | 1.02% |
AMICUS THERAPEUTICS INC | FOLD | 1.01% |
MIRATI THERAPEUT | MRTX | 0.91% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.87% |
INTELLIA THERAPE | NTLA | 0.83% |
CYTOKINETICS INC | CYTK | 0.82% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.82% |
KARUNA THERAPEUTICS INC | KRTX | 0.81% |
ULTRAGENYX PHARM | RARE | 0.80% |
BLUEPRINT MEDICI | BPMC | 0.79% |
GUARDANT HEALTH INC | GH | 0.76% |
DENALI THERAPEUT | DNLI | 0.75% |
BEAM THERAPEUTICS INC | BEAM | 0.67% |
BIOCRYST PHARM | BCRX | 0.66% |
IRONWOOD PHARMAC | IRWD | 0.65% |
PROTHENA CORP PL | PRTA | 0.60% |
CATALYST PHARMAC | CPRX | 0.57% |
TG THERAPEUTICS | TGTX | 0.53% |
TWIST BIOSCIENCE CORP | TWST | 0.52% |
PTC THERAPEUTICS | PTCT | 0.49% |
VIR BIOTECHNOLOGY INC | VIR | 0.48% |
NOVAVAX INC | NVAX | 0.39% |
MADRIGAL PHARMAC | MDGL | 0.31% |
Other (Cash, derivatives and other liabilities) | 0.03% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Fund Management (Europe) Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management.
© 2023 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.